<ul><li>Titan Medical Inc. provided a progress update on its planned merger with Conavi Inc.</li><li>The combined entity will continue working to commercialize Conavi's Novasight Hybrid system for guiding minimally invasive coronary procedures.</li><li>They are preparing submissions to list Titan shares on the TSX Venture Exchange and completing the management information circular.</li><li>Conavi is also preparing concurrent financing of subscription receipts worth $15 million to $20 million.</li></ul>

Titan Medical gives progress report about Conavi merger

Discover more